πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 46 of 200 Β· A–Z by INN

  1. creams

    NULL

    TGA: approved

  2. crinecerfont

    CRENESSITY NEUROCRINE BIOSCIENCES INC

    ORAL FDA: approved

  3. crisaborole

    STAQUIS

    TOPICAL FDA: approved Β· EMA: withdrawn

    D11AH06
  4. crisantaspase

    ENRYLAZE Jazz Pharmaceuticals Ireland Limited

    EMA: approved

    L01XX02
  5. crisugabalin

    NMPA: clinical trials

  6. crizanlizumab

    ADAKVEO

    EMA: unknown

    B06AX01
  7. crizanlizumab-tmca

    ADAKVEO

    INJECTION FDA: approved

  8. crizotinib

    XALKORI Pfizer Australia Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved Β· NMPA: clinical trials

    L01ED01
  9. crofelemer

    MYTESI

    ORAL FDA: approved

  10. cromolyn sodium

    CROMOLYN SODIUM Blackmores Limited

    OPHTHALMIC FDA: approved

  11. crotamiton

    EURAX

    TOPICAL FDA: approved

  12. crovalimab

    PIASKY

    EMA: approved Β· PMDA: approved

    L04AJ07
  13. crovalimab-akkz

    PIASKY

    INTRAVENOUS FDA: approved

  14. cryptenamine acetates

    UNITENSEN

    INJECTION FDA: approved

  15. cryptenamine tannates

    UNITENSEN

    ORAL FDA: approved

  16. cupric chloride

    CUPRIC CHLORIDE Amneal Pharma Europe Ltd

    INJECTION FDA: approved

  17. cupric sulfate

    CUPRIC SULFATE Regeneron Ireland Designated Activity Company (DAC)

    INJECTION FDA: approved

  18. cyanocobalamin

    CYANOCOBALAMIN Regeneron Ireland Designated Activity Company (DAC)

    N/A FDA: approved

  19. cyclacillin

    CYCLAPEN-W Teva Pharma GmbH

    ORAL FDA: approved

  20. cyclizine lactate

    MAREZINE

    INJECTION FDA: approved

  21. cyclobenzaprine hydrochloride

    CYCLOBENZAPRINE HYDROCHLORIDE Tonix Pharmaceuticals Holding

    ORAL FDA: approved

  22. cyclopentolate hydrochloride

    CYCLOGYL

    OPHTHALMIC FDA: approved

  23. cyclophosphamide

    CYCLONEX Amdipharm Mercury (Australia) Pty Limited

    SOLUTION FDA: approved Β· TGA: approved Β· NMPA: clinical trials

  24. cyclophosphomide

    NMPA: clinical trials

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources